The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Sacubitril And Valsartan (NDC 70771-1921). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1921-6
Sacubitril and valsartan tablets, 24 mg/26 mg
60 Tablets
Rx only
24 mg / 26 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 01)
NDC 70771-1922-6
Sacubitril and valsartan tablets, 49 mg/51 mg
60 Tablets
Rx only
49 mg/51 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 02)
NDC 70771-1923-6
Sacubitril and valsartan tablets, 97 mg/103 mg
60 Tablets
Rx only
97 mg/103 mg (F0d8c298 2823 4537 Ae02 C43da2c66e67 03)
* Please review the disclaimer below.
